Matthew Cameron Jones

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Pfizer Corporation. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Cameron Jones. Retrieved from https://idiyas.com/inventor/matthew-cameron-jones

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 13(Granted Patents)

Company Filing History:

4 out of 4,488

Pfizer Corporation

patents

Years Active: 2014-2019

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10278974 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one (2019-05-07),

2. 9861638 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one (2018-01-09),

3. 9045487 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one (2015-06-02),

4. 8754072 - Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one (2014-06-17),

Title: Matthew Cameron Jones: Innovator in Pharmaceutical Chemistry

Introduction

Matthew Cameron Jones is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on novel compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Jones has developed salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one. This invention relates to novel polymorphic forms of the compound and processes for their preparation. These polymorphic forms may serve as components of pharmaceutical compositions and could be utilized to treat mammalian disease conditions mediated by poly(ADP-ribose) polymerase activity, including cancer.

Career Highlights

Matthew Cameron Jones is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative treatments that address critical health issues.

Collaborations

Jones has collaborated with several esteemed colleagues in his field, including Patricia Ann Basford and Anthony Michael Campeta. These collaborations have further enhanced the impact of his research and innovations.

Conclusion

Matthew Cameron Jones is a distinguished inventor whose work in pharmaceutical chemistry has the potential to make a significant difference in the treatment of serious diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.